Oligonucleotide Therapeutics Society Inc
Oligonucleotide Therapeutics Society Inc's network
25 people2 organisationsi25 people and 2 organisations on this map.The large node is the subject of this page. Solid lines are what the register itself records (25). Violet dotted lines (2) are likely: the same full name sits on the current board of another organisation in the same register and region. Form 990 filings give names without a person identifier; SEC insider filings carry a CIK. It may be a different person.The board
25 listediTime on the board is observed from the annual filings: the IRS files no appointment date, so the bar counts years from the first filing the person appears on - a lower bound, not a filed start date. Names are exactly as filed. The IRS publishes no person identifier, so this edition does not yet link a person across organisations in the tables. The network map shows same-name matches as likely links only, never as confirmed.Time served and departures are observed across annual filings. Observed time served is a lower bound - a member may have joined before the first year on record. The organisation reported 25 voting members of its governing body on its latest Form 990 Part VI, which matches the board listed here.| Name | Role as filed | Since | On the board |
|---|---|---|---|
| Alex Garanto | Director | 2023 | 3 yrs |
| Anastasia Khvorova | Director | 2018 | 8 yrs |
| Annabelle Biscans | Company secretary | 2023 | 3 yrs |
| Arelie Goyenvalle | Director | 2023 | 3 yrs |
| Bruno Godinho | Director | 2022 | 4 yrs |
| David Corey | Past President | 2018 | 8 yrs |
| Eva-Marie Manz | Trainee Rep | 2023 | 3 yrs |
| Fritz Eckstein | Honorary Member | 2018 | 8 yrs |
| Hassan Fakih | Director | 2023 | 3 yrs |
| Jathavan Asohan | Trainee Rep | 2023 | 3 yrs |
| Jillian Belgrad | Trainee Rep | 2023 | 3 yrs |
| John Rossi | Honorary Member | 2018 | 8 yrs |
| Julia Alterman | Director | 2023 | 3 yrs |
| Krystal Johnson | Trainee Rep | 2023 | 3 yrs |
| Maja Janas De Angelis (also filed as Maja Janas De Angelis) | Director | 2022 | 4 yrs |
| Mano Manoharan | Honorary Member | 2023 | 3 yrs |
| Marie Wikstrom Lindholm | Director | 2022 | 4 yrs |
| Martin Maier | Treasurer | 2019 | 7 yrs |
| Masad J Damha | Director | 2022 | 4 yrs |
| Mike Gait | Honorary Member | 2018 | 8 yrs |
| Rebecca Miles | Incoming Pres. | 2022 | 4 yrs |
| Richard Geary | President | 2019 | 7 yrs |
| Shalini Andersson | Director | 2019 | 7 yrs |
| Shuling GUO | Director | 2023 | 3 yrs |
| Timothy YU (also filed as Timothy Yu) | Director | 2022 | 4 yrs |
Pay and hours
year to 31 December 2025iFrom Part VII of the Form 990: compensation reported for each officer, director, trustee, key employee and highest-paid staff member, and the average hours a week they report. Most board members are unpaid; a blank means nothing was reported. Pay from related organisations is shown separately.| Name | Title as filed | Hours a week | Pay from the organisation | Related organisations | Other |
|---|---|---|---|---|---|
| Richard Geary | Past President | 1 | $0 | ||
| Rebecca Miles | President | 1 | $0 | ||
| Annabelle Biscans | Director | 1 | $0 | ||
| Julia Alterman | Director | 1 | $0 | ||
| Masad J Damha | Honorary Member | 1 | $0 | ||
| Hassan Fakih | Director | 1 | $0 | ||
| Alex Garanto | Secretary | 1 | $0 | ||
| Bruno Godinho | Director | 1 | $0 | ||
| Arelie Goyenvalle | Director | 1 | $0 | ||
| Maja Janas de Angelis | Treasurer | 1 | $0 | ||
| Anastasia Khvorova | Director | 1 | $0 | ||
| Marie Wikstrom Lindholm | Director | 1 | $0 | ||
| Timothy Yu | Director | 1 | $0 | ||
| Krystal Johnson | Director | 1 | $0 | ||
| Fritz Eckstein | Honorary Member | 1 | $0 | ||
| Mike Gait | Honorary Member | 1 | $0 | ||
| Mano Manoharan | Honorary Member | 1 | $0 | ||
| John Rossi | Honorary Member | 1 | $0 | ||
| Laura Sepp-Lorenzino | President Elect | 1 | $0 | ||
| Annemieke Aartsma-Rus | Director | 1 | $0 | ||
| Helene Tran | Director | 1 | $0 | ||
| Jonathan K Watts | Director | 1 | $0 | ||
| Sarah Allen | Trainee Rep | 1 | $0 | ||
| Ilaria Brentari | Trainee Rep | 1 | $0 | ||
| Daniel Knight | Trainee Rep | 1 | $0 | ||
| Emilio Harris-Mostert | Trainee Rep | 1 | $0 |
No pay was reported for anyone in Part VII on this return.
About
- Legal name
- Oligonucleotide Therapeutics Society Inc
- EIN
- 571162250
- Address
- 3960 W Point Loma Blvd H Box 346, San Diego, CA, 92110-5643
- State
- California
- Mission
- OTS is an educational organization that brings together scientists from around the world to share research and foster collaborations in an effort to further the development of oligonucleotide therapeutic drug development. (as filed on the Form 990)
- Activity (NTEE)
- H99 Medical research
- IRS classification
- 501(c)06 (tax-exempt under section 501(c)(3) where shown)
- Classified purpose
- Medical Research
- Size band
- 6 (IRS master file code)
- Formed
- 2002
- Principal officer
- Rebecca Miles (as named on the Form 990)
- IRS ruling date
- 1 August 2014
- Status
- Code 01 (unconditional exemption)
- Form 990 filings on record
- 5, latest 2023
Most connected
Longest observed on the filings
≥8years on the filingsAnastasia Khvorova
≥8years on the filingsDavid Corey
≥8years on the filingsFritz Eckstein
≥8years on the filingsJohn Rossi
Latest return
year to 31 December 2025iFigures from the newest Form 990 or 990-EZ in the IRS e-file releases of 2025 and 2026, for the year ending 31 December 2025. US dollars, as filed.- Total assets
- $2.3m
- Total liabilities
- $0
- Net assets or fund balances
- $2.3m
- Contributions and grants received
- $6k
- Program service revenue
- $1.7m
- Grants and similar paid out
- $113k
- Employees
- 0
- Volunteers
- 39